From the Division of Trauma, Emergency Surgery, and Surgical Critical Care (Dorken Gallastegi, Saillant, Hwabejire, Fawley, Parks, Kaafarani, Velmahos).
Department of Surgery (Secor, Maurer).
J Am Coll Surg. 2022 Sep 1;235(3):468-480. doi: 10.1097/XCS.0000000000000268. Epub 2022 Aug 10.
Using a large national database, we evaluated the relationship between RBC transfusion volume, RBC transfusion rate, and in-hospital mortality to explore the presence of a futility threshold in trauma patients receiving ultramassive blood transfusion.
The ACS-TQIP 2013 to 2018 database was analyzed. Adult patients who received ultramassive blood transfusion (≥20 units of RBC/24 hours) were included. RBC transfusion volume and rate were captured at the only 2 time points available in TQIP (4 hours and 24 hours), or time of death, whichever came first.
Among 5,135 patients analyzed, in-hospital mortality rate was 62.1% (n = 3,190), and 4-hour and 24-hour mortality rates were 17.53% (n = 900) and 42.41% (n = 2,178), respectively. RBC transfusion volumes at 4 hours (area under the receiver operating characteristic curve [AUROC] 0.59 [95% CI 0.57 to 0.60]) and 24 hours (AUROC 0.59 [95% CI 0.57 to 0.60]) had low discriminatory ability for mortality and were inconclusive for futility. Mean RBC transfusion rates calculated within 4 hours (AUROC 0.65 [95% CI 0.63 to 0.66]) and 24 hours (AUROC 0.85 [95% CI 0.84 to 0.86]) had higher discriminatory ability than RBC transfusion volume. A futility threshold was not found for the mean RBC transfusion rate calculated within 4 hours. All patients with a final mean RBC transfusion rate of ≥7 U/h calculated within 24 hours of arrival experienced in-hospital death (n = 1,326); the observed maximum length of survival for these patients during the first 24 hours ranged from 24 hours for a rate of 7 U/h to 4.5 hours for rates ≥21 U/h.
RBC transfusion volume within 4 or 24 hours and mean RBC transfusion rate within 4 hours were not markers of futility. The observed maximum length of survival per mean RBC transfusion rate could inform resuscitation efforts in trauma patients receiving ongoing transfusion between 4 and 24 hours.
利用大型国家数据库,我们评估了红细胞输注量、红细胞输注率与院内死亡率之间的关系,以探讨接受超大剂量输血的创伤患者是否存在无效阈值。
分析了 ACS-TQIP 2013 至 2018 年数据库。纳入接受超大剂量输血(≥20 单位 RBC/24 小时)的成年患者。在 TQIP 中仅可获得红细胞输注量和输注率的两个时间点(4 小时和 24 小时)或死亡时间的数据,以先出现者为准。
在分析的 5135 例患者中,院内死亡率为 62.1%(n=3190),4 小时和 24 小时死亡率分别为 17.53%(n=900)和 42.41%(n=2178)。4 小时(接受者操作特征曲线下面积 [AUROC]0.59[95%CI0.57 至 0.60])和 24 小时(AUROC0.59[95%CI0.57 至 0.60])的红细胞输注量对死亡率的区分能力较低,且对无效性的判断尚无定论。4 小时内计算的平均红细胞输注率(AUROC0.65[95%CI0.63 至 0.66])和 24 小时内计算的平均红细胞输注率(AUROC0.85[95%CI0.84 至 0.86])具有更高的区分能力。在 4 小时内计算的平均红细胞输注率未发现无效阈值。所有在入院后 24 小时内最终平均红细胞输注率≥7U/h 的患者均经历院内死亡(n=1326);这些患者在入院后前 24 小时内观察到的最长生存时间从 7U/h 时的 24 小时到 21U/h 时的 4.5 小时不等。
4 小时或 24 小时内的红细胞输注量以及 4 小时内的平均红细胞输注率均不是无效的标志。根据平均红细胞输注率观察到的最长生存时间可指导创伤患者在 4 至 24 小时持续输血期间的复苏努力。